Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: REVVITY HEALTH SCIENCES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-08-21 to 2025-10-31
Current total value of award: $11322.28
Description: REVVITY HEALTH SCIENCES, INC:1106024 [25-004016] H] DAMGO, [3H] ENKEPHALIN, AND [3H] U69,593 IN ORDER TO PERFORM ONGOING BINDING EXPERIMENTS TO STUDY NEWLY EMERGING DRUGS OF ABUSE.